News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,942 Results
Type
Article (87369)
Company Profile (759)
Press Release (771788)
Multimedia
Podcasts (169)
Webinars (28)
Section
Business (233030)
Career Advice (4137)
Deals (39788)
Drug Delivery (134)
Drug Development (91235)
Employer Resources (202)
FDA (18273)
Job Trends (17396)
News (397330)
Policy (39920)
Tag
Academia (3003)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (142)
Alzheimer's disease (1673)
Antibody-drug conjugate (ADC) (221)
Approvals (18281)
Artificial intelligence (477)
Autoimmune disease (67)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (122)
Brain cancer (52)
Breast cancer (472)
Cancer (3763)
Cardiovascular disease (333)
Career advice (3553)
Career pathing (37)
CAR-T (241)
CDC (54)
Cell therapy (669)
Cervical cancer (32)
Clinical research (75233)
Collaboration (1350)
Company closure (4)
Compensation (919)
Complete response letters (59)
COVID-19 (2948)
CRISPR (81)
C-suite (563)
Cystic fibrosis (132)
Data (4174)
Decentralized trials (2)
Denatured (60)
Depression (108)
Diabetes (444)
Diagnostics (7081)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (228)
Drug pricing (183)
Drug shortages (36)
Duchenne muscular dystrophy (197)
Earnings (98724)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132725)
Executive appointments (977)
FDA (20657)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1224)
Gene editing (170)
Generative AI (45)
Gene therapy (531)
GLP-1 (1011)
Government (5374)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (51)
Infectious disease (3179)
Inflammatory bowel disease (184)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (183)
Interviews (815)
IPO (17925)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (635)
Leadership (32)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (534)
Lymphoma (258)
Machine learning (27)
Management (66)
Manufacturing (620)
MASH (133)
Medical device (14854)
Medtech (14875)
Mergers & acquisitions (22723)
Metabolic disorders (1134)
Multiple sclerosis (136)
NASH (23)
Neurodegenerative disease (221)
Neuropsychiatric disorders (59)
Neuroscience (2681)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (57)
Obesity (554)
Opinion (309)
Ovarian cancer (123)
Pain (161)
Pancreatic cancer (165)
Parkinson's disease (236)
Partnered (28)
Patents (408)
Patient recruitment (297)
Peanut (57)
People (66200)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23195)
Phase II (32675)
Phase III (24575)
Pipeline (2630)
Policy (291)
Postmarket research (3554)
Preclinical (10471)
Press Release (72)
Prostate cancer (191)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (647)
Real estate (7421)
Recruiting (78)
Regulatory (27913)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (13)
RNA editing (15)
RSV (70)
Schizophrenia (133)
Series A (202)
Series B (150)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (91)
The Weekly (107)
Vaccines (1031)
Venture capital (66)
Weight loss (391)
Women's health (58)
Worklife (21)
Date
Today (148)
Last 7 days (588)
Last 30 days (2416)
Last 365 days (33645)
2025 (25481)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50893)
Australia (8944)
California (9263)
Canada (2808)
China (869)
Colorado (394)
Connecticut (411)
Delaware (256)
Europe (116960)
Florida (1362)
Georgia (310)
Hawaii (3)
Idaho (67)
Illinois (802)
India (47)
Indiana (450)
Iowa (19)
Japan (306)
Kansas (123)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1255)
Massachusetts (6971)
Michigan (307)
Minnesota (556)
Mississippi (4)
Missouri (116)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2557)
New Mexico (32)
New York (2530)
North Carolina (1395)
North Dakota (10)
Northern California (4159)
Ohio (290)
Oklahoma (20)
Oregon (50)
Pennsylvania (1928)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3541)
Tennessee (148)
Texas (1448)
United States (34282)
Utah (275)
Virginia (243)
Washington D.C. (83)
Washington State (799)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,942 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
October 9, 2025
·
6 min read
Press Releases
ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® (epinephrine nasal spray)
October 9, 2025
·
8 min read
Press Releases
Ashvattha Therapeutics to Present Phase 2 DME and nAMD Data at Innovate Retina
October 9, 2025
·
2 min read
Press Releases
Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
October 9, 2025
·
4 min read
Press Releases
Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS
October 9, 2025
·
5 min read
Press Releases
Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform
October 9, 2025
·
5 min read
Press Releases
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
October 9, 2025
·
10 min read
Press Releases
CREATE Medicines Strengthens Executive Team with Appointment of Veteran Biopharma Leader Allan L. Shaw as CFO and CBO
October 9, 2025
·
3 min read
Press Releases
Arthrosi Secures $153 Million in Series E Financing to Complete Pivotal Development of Pozdeutinurad for the Treatment of Gout and Tophaceous Gout
October 9, 2025
·
3 min read
Press Releases
BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS
October 9, 2025
·
7 min read
1 of 85,995
Next
